2nd US patent granted for therapeutic antibodies for Parkinson’s disease

On October 14th 2014 the US patent office granted BioArctic a 2nd US patent (US 8859501) covering therapeutic antibodies for Parkinson’s disease.

The patent claims certain important domains (CDR-region) on antibodies which confers high specific binding to toxic forms of alpha-synuclein that are believed to cause Parkinson’s disease.